Ze Zhang
No. 13 Hangkong Road
Wuhan, 430030, China
Wuhan, 430030, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Comparative safety and efficacy of hepatic arterial infusion chemotherapy combined with targeted therapy and immunotherapy, with or without transarterial chemoembolization, in unresectable hepatocellular carcinoma: a multicenter retrospective cohort study.
Journal: BMC gastroenterology
Published: January 08, 2026
Clinical MRI-radiomics model based on support vector machine to predict the efficacy of first transarterial chemoembolization for unresectable intrahepatic cholangiocarcinoma.
Journal: La Radiologia medica
Published: March 29, 2025
Targeting TM4SF1 promotes tumor senescence enhancing CD8+ T cell cytotoxic function in hepatocellular carcinoma.
Journal: Clinical and molecular hepatology
Published: October 28, 2024
Hepatic arterial infusion chemotherapy versus transarterial chemoembolization in patients with unresectable intrahepatic cholangiocarcinoma: a multicenter retrospective cohort study.
Journal: European radiology
Published: September 05, 2024
Correction: Systemic chemotherapy plus transarterial chemoembolization versus systemic chemotherapy alone for unresectable intrahepatic cholangiocarcinoma: a multicenter retrospective cohort study.
Journal: La Radiologia medica
Published: May 13, 2024
Systemic chemotherapy plus transarterial chemoembolization versus systemic chemotherapy alone for unresectable intrahepatic cholangiocarcinoma: a multicenter retrospective cohort study.
Journal: La Radiologia medica
Published: July 14, 2023
Targeting VPS72 inhibits ACTL6A/MYC axis activity in HCC progression.
Journal: Hepatology (Baltimore, Md.)
Published: July 20, 2022
The importance of N6-methyladenosine modification in tumor immunity and immunotherapy.
Journal: Experimental hematology & oncology
Published: March 11, 2022
Showing 1-9 of 9
Last Updated: 09/26/2026